SG11201908274YA - Il-1r-i binding polypeptide - Google Patents

Il-1r-i binding polypeptide

Info

Publication number
SG11201908274YA
SG11201908274YA SG11201908274YA SG11201908274YA SG 11201908274Y A SG11201908274Y A SG 11201908274YA SG 11201908274Y A SG11201908274Y A SG 11201908274YA SG 11201908274Y A SG11201908274Y A SG 11201908274YA
Authority
SG
Singapore
Prior art keywords
international
pct
binding polypeptide
binding
danderyd
Prior art date
Application number
Other languages
English (en)
Inventor
Joachim Feldwisch
Malin Lindborg
Joakim Nilsson
Erik Nordling
Robert Svensson
Original Assignee
Swedish Orphan Biovitrum Ab Publ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Swedish Orphan Biovitrum Ab Publ filed Critical Swedish Orphan Biovitrum Ab Publ
Publication of SG11201908274YA publication Critical patent/SG11201908274YA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2318/00—Antibody mimetics or scaffolds
    • C07K2318/20—Antigen-binding scaffold molecules wherein the scaffold is not an immunoglobulin variable region or antibody mimetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
SG11201908274Y 2017-03-31 2018-04-03 Il-1r-i binding polypeptide SG11201908274YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17164226 2017-03-31
PCT/EP2018/058448 WO2018178392A1 (fr) 2017-03-31 2018-04-03 Polypeptide de liaison à l'il-1r-i

Publications (1)

Publication Number Publication Date
SG11201908274YA true SG11201908274YA (en) 2019-10-30

Family

ID=58536721

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201908274Y SG11201908274YA (en) 2017-03-31 2018-04-03 Il-1r-i binding polypeptide

Country Status (14)

Country Link
US (1) US20210403533A1 (fr)
EP (1) EP3601317A1 (fr)
JP (2) JP2020515252A (fr)
KR (1) KR20190134617A (fr)
CN (1) CN110650971A (fr)
AR (1) AR111348A1 (fr)
AU (1) AU2018242224B2 (fr)
BR (1) BR112019019819A2 (fr)
CA (1) CA3056985A1 (fr)
IL (1) IL269477B1 (fr)
MX (1) MX2019011191A (fr)
SG (1) SG11201908274YA (fr)
UY (1) UY37651A (fr)
WO (1) WO2018178392A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021089695A1 (fr) * 2019-11-05 2021-05-14 Affibody Ab Polypeptides

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148009B1 (ko) 1988-05-27 1998-08-01 그래고리 비. 아보트 인터루킨-1 억제제
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
ES2649037T3 (es) 2000-12-12 2018-01-09 Medimmune, Llc Moléculas con semividas prolongadas, composiciones y usos de las mismas
DK2213685T3 (en) 2002-09-06 2014-03-03 Medarex Llc Therapeutic anti-IL-1R1 monoclonal antibody
JP4871126B2 (ja) * 2003-07-04 2012-02-08 アフィボディ・アーベー Ｈｅｒ２に対する結合親和性を有するポリペプチド
AR045614A1 (es) 2003-09-10 2005-11-02 Hoffmann La Roche Anticuerpos contra el recepctor de la interleuquina- 1 y los usos de los mismos
EP1957536A2 (fr) * 2005-12-01 2008-08-20 Domantis Limited Formats d'anticorps a domaine non competitif qui lient le recepteur type 1 d'interleukine 1
MX2009013137A (es) * 2007-06-06 2010-04-30 Domantis Ltd Metodos para seleccionar polipeptidos resistentes a la proteasa.
EP2231860B1 (fr) 2007-12-19 2011-10-05 Affibody AB Polypeptide dérivé d'une protéine et se liant au pdgf
ES2532461T3 (es) 2007-12-26 2015-03-27 Xencor, Inc. Variantes de FC con enlazamiento alterado a FCRN
US8298533B2 (en) * 2008-11-07 2012-10-30 Medimmune Limited Antibodies to IL-1R1
US8748581B2 (en) * 2009-04-10 2014-06-10 Ablynx N.V. Anti-IL-6R polypeptides and pharmaceutical compositions thereof
US9175067B2 (en) * 2010-03-08 2015-11-03 Ge Healthcare Bio-Sciences Ab Immunoglobulin G Fc region binding polypeptide
WO2013126006A1 (fr) * 2012-02-20 2013-08-29 Swedish Orphan Biovitrum Ab (Publ) Polypeptides se fixant au composant c5 du complément humain
PL2912054T3 (pl) * 2012-10-25 2017-11-30 Affibody Ab Polipeptyd wiążący albuminę
DK2970406T3 (en) * 2013-03-15 2018-02-05 Affibody Ab New polypeptides
WO2015028558A1 (fr) * 2013-08-28 2015-03-05 Swedish Orphan Biovitrum Ab (Publ) Polypeptides stables se liant au c5 du complément humain
WO2015091957A1 (fr) * 2013-12-20 2015-06-25 Affibody Ab Polypeptide modifié liant l'albumine
JP7028557B2 (ja) 2014-06-13 2022-03-02 アフィボディ アクティエボラーグ 新規ポリペプチド
WO2016059057A1 (fr) * 2014-10-13 2016-04-21 Affibody Ab Polypeptides se liant au vegfr-2
MX2017008660A (es) * 2015-01-12 2017-11-17 Affibody Ab Polipeptidos enlazados a il-17a.
JP2023023582A (ja) * 2021-08-05 2023-02-16 栗田工業株式会社 感染症対策装置、プログラム、および感染症対策方法

Also Published As

Publication number Publication date
KR20190134617A (ko) 2019-12-04
AU2018242224B2 (en) 2021-09-02
IL269477B1 (en) 2024-02-01
CA3056985A1 (fr) 2018-10-04
WO2018178392A1 (fr) 2018-10-04
JP2023071776A (ja) 2023-05-23
IL269477A (en) 2019-11-28
JP2020515252A (ja) 2020-05-28
BR112019019819A2 (pt) 2020-04-22
EP3601317A1 (fr) 2020-02-05
AU2018242224A1 (en) 2019-10-17
AR111348A1 (es) 2019-07-03
CN110650971A (zh) 2020-01-03
MX2019011191A (es) 2019-12-11
US20210403533A1 (en) 2021-12-30
UY37651A (es) 2018-10-31

Similar Documents

Publication Publication Date Title
SG11201903359RA (en) Bispecific antibody against bcma and cd3 and an immunological drug for combined use in treating multiple myeloma
SG11201907912YA (en) An appliance operation signal processing system and method
SG11201806404SA (en) Systems and methods for storing and sharing transactional data using distributed computer systems
SG11201811363YA (en) Anti-zika virus antibodies and methods of use
SG11201407580YA (en) Composition comprising two antibodies engineered to have reduced and increased effector function
SG11201407800SA (en) Selective binding of biological targets to solid phase ureides
SG11201903693QA (en) Polypeptide variants and uses thereof
SG11201903202VA (en) Osmotic membrane
SG11201808476SA (en) Recycling of polymer matrix composite
SG11201809620UA (en) The contorsbody - a single chain target binder
SG11201906961UA (en) Polypeptide variants and uses thereof
SG11201809341PA (en) Mobile robot
SG11201805001UA (en) Method of treating influenza a
SG11201900085TA (en) Modified ligand-gated ion channels and methods of use
SG11201907927SA (en) Binding molecules that specifically bind to tau
SG11201809097WA (en) Reconfigurable distributed processing
SG11201910145PA (en) Methods and apparatuses for control resource bundling and mapping in wireless communication systems
SG11201908275XA (en) Peptides and methods for the treatment of diabetes
SG11201908744PA (en) Anti-c5a antibodies and uses thereof
SG11201809473QA (en) Humanized anti-basigin antibodies and the use thereof
SG11201907208XA (en) Radiolabeled anti-lag3 antibodies for immuno-pet imaging
SG11201909048TA (en) Use of klk5 antagonists for treatment of a disease
SG11201804083QA (en) Opposite ph-salt gradients for improved protein separations
SG11201908238SA (en) Anti-c5 antibodies and uses thereof
SG11201909080XA (en) Method and system for the removal of noxious compounds from flue-gas using an scr catalyst